BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35721741)

  • 1. Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis.
    Beitl K; Dewailly D; Seemann R; Hager M; Bünker J; Mayrhofer D; Holzer I; Ott J
    Front Endocrinol (Lausanne); 2022; 13():904706. PubMed ID: 35721741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E; Fruzzetti F; Lobo RA
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual functioning in women with functional hypothalamic amenorrhea: exploring the relevance of an underlying polycystic ovary syndrome (PCOS)-phenotype.
    Barbagallo F; Pedrielli G; Bosoni D; Tiranini L; Cucinella L; Calogero AE; Facchinetti F; Nappi RE
    J Endocrinol Invest; 2023 Aug; 46(8):1623-1632. PubMed ID: 36735200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum LH levels are associated to serum insulin and Anti-Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology.
    Makolle S; Catteau-Jonard S; Robin G; Dewailly D
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):73-78. PubMed ID: 36912207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the serum level of anti-Müllerian hormone in patients with functional hypothalamic anovulation.
    Makolle S; Catteau-Jonard S; Robin G; Dewailly D
    Hum Reprod; 2021 Mar; 36(4):1043-1051. PubMed ID: 33580689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
    Piltonen TT; Komsi E; Morin-Papunen LC; Korhonen E; Franks S; Järvelin MR; Arffman RK; Ollila MM
    Eur J Endocrinol; 2023 Jun; 188(6):547-554. PubMed ID: 37294941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhoea and polycystic ovarian syndrome: A retrospective observational study.
    Abou Sherif S; Newman R; Haboosh S; Al-Sharefi A; Papanikolaou N; Dimakopoulou A; Webber LJ; Abbara A; Franks S; Dhillo WS; Jayasena CN
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):618-627. PubMed ID: 34323305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Reprod Biol Endocrinol; 2016 Apr; 14(1):24. PubMed ID: 27129705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress and polycystic ovarian morphology in functional hypothalamic amenorrhea: a retrospective cohort study.
    Hager M; Dewailly D; Marculescu R; Ghobrial S; Parry JP; Ott J
    Reprod Biol Endocrinol; 2023 May; 21(1):42. PubMed ID: 37170133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E; Fruzzetti F; Lobo RA
    Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology.
    Hager M; Ott J; Marschalek J; Marschalek ML; Kinsky C; Marculescu R; Dewailly D
    Reprod Biol Endocrinol; 2022 Jul; 20(1):98. PubMed ID: 35787707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS).
    Phylactou M; Clarke SA; Patel B; Baggaley C; Jayasena CN; Kelsey TW; Comninos AN; Dhillo WS; Abbara A
    Clin Endocrinol (Oxf); 2021 Aug; 95(2):239-252. PubMed ID: 33354766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
    Wang JG; Lobo RA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1394-7. PubMed ID: 18230664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology.
    Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G
    Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LH:FSH Ratio in Functional Hypothalamic Amenorrhea: An Observational Study.
    Boegl M; Dewailly D; Marculescu R; Steininger J; Ott J; Hager M
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome.
    Sharquie KE; Al-Bayatti AA; Al-Ajeel AI; Al-Bahar AJ; Al-Nuaimy AA
    Saudi Med J; 2007 Jul; 28(7):1039-43. PubMed ID: 17603706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study.
    Zhang M; Liu X; Xu X; Li J; Bu Z; Yang Q; Shi H; Niu W; Dai S; Liang Y; Guo Y
    Reprod Biol Endocrinol; 2023 Feb; 21(1):15. PubMed ID: 36726106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.